Actively Recruiting

Phase Not Applicable
Age: 25Years - 49Years
FEMALE
NCT07428330

Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women With HIV

Led by UNC Lineberger Comprehensive Cancer Center · Updated on 2026-04-27

2912

Participants Needed

1

Research Sites

83 weeks

Total Duration

On this page

Sponsors

U

UNC Lineberger Comprehensive Cancer Center

Lead Sponsor

N

National Cancer Institute (NCI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This Clinical Trials Network for Human Immunodeficiency Virus (HIV)-Associated Cervical Cancer Screening and Treatment Optimization (CASCADE) C3001-A trial aims to assess how the introduction of a community-health-worker-facilitated model, in addition to the existing static clinic-only model, influences the rates of cervical cancer screening uptake among women living with HIV (WLWH). This study involves offering human papillomavirus (HPV) self-collection for cervical cancer screening to eligible WLWH. The 'CASCADE' Network is a clinical trials network aimed at improving cervical cancer screening, management, and pre-cancer treatment for WLWH, in various healthcare settings. The network will conduct implementation trials to improve the triage of HPV-positive WLWH, as well as algorithms to optimize access to and options for effective treatment. Trials will be conducted using a mixed-methods approach aimed at assessing implementation strategies and outcomes and their potential to integrate into existing health systems. Further understanding of HPV-based community-based strategies to reach WLWH, and the acceptability, feasibility, appropriateness, and cost of these strategies will be valuable for cervical cancer screening programs serving WLWH. Inputs from various 'CASCADE' Clinical Sites (CS) regarding feasible screening outreach options available in their settings for WLWH have guided this study that focuses on evaluating a pragmatic HPV self-collection implementation model to improve access to screening. While it is clear that HPV self-collection is a highly acceptable and feasible screening option, creating opportunities to conduct self-collection in alternative venues outside the clinic premises, and with the guidance of and facilitation by trusted community healthcare workers is an important implementation strategy that needs to be evaluated and considered for its potential benefit. Studies have not yet evaluated a community-based approach for HPV self-collection kit distribution among WLWH - who may have different characteristics, preferences, and access to screening services than women not living with HIV. Providing WLWH with the option of receiving HPV self-collection kits in their own homes or other community-based settings ('community-based HPV self-collection') is a novel implementation strategy that could improve cervical cancer screening rates among eligible women. Therefore, this novel trial aims to evaluate the feasibility and effectiveness of implementing community-based HPV self-collection among WLWH.

CONDITIONS

Official Title

Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women With HIV

Who Can Participate

Age: 25Years - 49Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Women living with HIV aged 25 to 49 years or as recommended by Uganda's Ministry of Health cervical cancer guidelines
  • Live in catchment areas of or attend study-eligible clinics
  • Eligible for HPV-based cervicovaginal testing due to never having been screened or being due for follow-up screening
  • Attending clinics that provide HIV care and distribute antiretroviral therapy to WLWH
  • Clinics able to collect their own data
  • Clinics may be supported by national programs or bilateral donor-funded initiatives
Not Eligible

You will not qualify if you...

  • Previous removal of the cervix
  • Currently pregnant or less than 3 months post-delivery
  • Positive on most recent cervical cancer screening and did not complete referral for further evaluation or treatment
  • Previously treated for invasive cervical cancer

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Makerere University Walter Reed Program

Kampala, Uganda, 16524

Actively Recruiting

Loading map...

Research Team

J

Jennifer S Smith, PhD

CONTACT

F

Franklin K Okwunze, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SCREENING

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here